Ken Fisher Intercept Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$19.33 - $37.75 $1.16 Million - $2.26 Million	-59,970 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$24.48 - $42.47 $70,331 - $122,016	-2,873 Reduced 4.57%	59,970 $1.48 Million
Q3 2020 Nov 10, 2020	SELL	$39.09 - $53.44 $166,836 - $228,081	-4,268 Reduced 6.36%	62,843 $2.61 Million
Q2 2020 Aug 07, 2020	SELL	$46.7 - $92.04 $6,864 - $13,529	-147 Reduced 0.22%	67,111 $3.22 Million
Q1 2020 Apr 28, 2020	SELL	$48.35 - $118.68 $384,769 - $944,455	-7,958 Reduced 10.58%	67,258 $4.24 Million
Q4 2019 Feb 12, 2020	SELL	$57.36 - $124.1 $308,940 - $668,402	-5,386 Reduced 6.68%	75,216 $9.32 Million
Q3 2019 Oct 29, 2019	BUY	$58.69 - $80.46 $28,934 - $39,666	493 Added 0.62%	80,602 $5.35 Million
Q2 2019 Jul 30, 2019	BUY	$77.77 - $120.68 $3.27 Million - $5.08 Million	42,099 Added 110.76%	80,109 $6.37 Million
Q1 2019 Apr 22, 2019	BUY	$91.83 - $120.68 $4,224 - $5,551	46 Added 0.12%	38,010 $4.25 Million
Q4 2018 Jan 25, 2019	SELL	$85.79 - $126.46 $43,838 - $64,621	-511 Reduced 1.33%	37,964 $3.83 Million
Q3 2018 Oct 24, 2018	SELL	$88.49 - $127.55 $540,850 - $779,585	-6,112 Reduced 13.71%	38,475 $4.86 Million
Q2 2018 Jul 09, 2018	BUY	$60.0 - $85.67 $290,100 - $414,214	4,835 Added 12.16%	44,587 $3.74 Million
Q1 2018 May 11, 2018	SELL	$52.72 - $67.25 $1.61 Million - $2.05 Million	-30,500 Reduced 43.42%	39,752 $2.45 Million
Q1 2018 Apr 19, 2018	BUY	$52.72 - $67.25 $1.6 Million - $2.04 Million	30,400 Added 76.28%	70,252 $4.32 Million
Q4 2017 Jan 24, 2018	BUY	$58.2 - $72.76 $1.54 Million - $1.92 Million	26,416 Added 196.61%	39,852 $2.33 Million
Q3 2017 Oct 17, 2017	BUY	$57.01 - $118.75 $765,986 - $1.6 Million	13,436	13,436 $780,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account